Paper40832004
PROTAC technology for prostate cancer treatment.
Wang Z and 3 others. Acta Mater Med, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. PROTAC technology for prostate cancer treatment. Papers, record 40832004. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40832004
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA177910 | NCI NIH HHS | United States | R01CA177910 | PubMed and NIH |
Source NIH RePORTER
References222
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37774414 | Methylated Nucleotide-Based Proteolysis-Targeting Chimera Enables Targeted Degradation of Methyl-CpG-Binding Protein 2. | J Am Chem Soc | 2023 | https://conductscience.org/library/papers/37774414 | PubMed |
| 2 | 28624514 | Bromodomain-containing proteins in prostate cancer. | Mol Cell Endocrinol | 2018 | https://conductscience.org/library/papers/28624514 | PubMed |
| 3 | 32297626 | A caged E3 ligase ligand for PROTAC-mediated protein degradation with light. | Chem Commun (Camb) | 2020 | https://conductscience.org/library/papers/32297626 | PubMed |
| 4 | 12015328 | Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12015328 | PubMed |
| 5 | 23228172 | Abiraterone in metastatic prostate cancer without previous chemotherapy. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23228172 | PubMed |
| 6 | 33652354 | Discovery of A031 as effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33652354 | PubMed |
| 7 | 9521705 | Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding. | Biochemistry | 1998 | https://conductscience.org/library/papers/9521705 | PubMed |
| 8 | 21925305 | Prostate cancer as a model system for genetic diversity in tumors. | Adv Cancer Res | 2011 | https://conductscience.org/library/papers/21925305 | PubMed |
| 9 | 33750801 | A noncanonical AR addiction drives enzalutamide resistance in prostate cancer. | Nat Commun | 2021 | https://conductscience.org/library/papers/33750801 | PubMed |
| 10 | 15027889 | Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate. | Endocr Relat Cancer | 2004 | https://conductscience.org/library/papers/15027889 | PubMed |
| 11 | 34783801 | G4-PROTAC: targeted degradation of a G-quadruplex binding protein. | Chem Commun (Camb) | 2021 | https://conductscience.org/library/papers/34783801 | PubMed |
| 12 | 35719272 | Biomarkers for prostate cancer detection and risk stratification. | Ther Adv Urol | 2022 | https://conductscience.org/library/papers/35719272 | PubMed |
| 13 | 30012605 | Delineating the role of cooperativity in the design of potent PROTACs for BTK. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30012605 | PubMed |
| 14 | 32559502 | Specific Knockdown of α-Synuclein by Peptide-Directed Proteasome Degradation Rescued Its Associated Neurotoxicity. | Cell Chem Biol | 2020 | https://conductscience.org/library/papers/32559502 | PubMed |
| 15 | 10606244 | DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. | Cancer Res | 1999 | https://conductscience.org/library/papers/10606244 | PubMed |
| 16 | 15837926 | Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15837926 | PubMed |
| 17 | 4912931 | The absorption and malabsorption of folic acid and its polyglutamates. | Am J Med | 1970 | https://conductscience.org/library/papers/4912931 | PubMed |
| 18 | 11971763 | Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cells. | Biochem J | 2002 | https://conductscience.org/library/papers/11971763 | PubMed |
| 19 | 15327770 | TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. | Mol Cell | 2004 | https://conductscience.org/library/papers/15327770 | PubMed |
| 20 | 25512207 | Targeting heat shock proteins in metastatic castration-resistant prostate cancer. | Nat Rev Urol | 2015 | https://conductscience.org/library/papers/25512207 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42382546 | Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects. | Prostate Int | 2026 | https://conductscience.org/library/papers/42382546 | PubMed |
| 42038292 | International standards and good practice guidelines in traditional, complementary and integrative medicine: a scoping review. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42038292 | PubMed |
| 41220927 | PROTAC: a revolutionary technology propelling small molecule drugs into the next golden age. | Front Oncol | 2025 | https://conductscience.org/library/papers/41220927 | PubMed |
| 40430296 | PROTAC Technology as a New Tool for Modern Pharmacotherapy. | Molecules | 2025 | https://conductscience.org/library/papers/40430296 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AR | 367 | PubTator's text mining | https://conductscience.org/library/genes/367 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40832004
GET https://conductscience.org/api/papers/v1/40832004/references?page=2